DOI:
10.1055/s-00000011
DMW - Deutsche Medizinische Wochenschrift
LinksClose Window
References
O’Donoghue MLG, López JA, Knusel B. et al.
Study design and rationale for the Olpasiran trials of Cardiovascular Events And lipoproteiN(a) reduction-DOSE finding study (OCEAN(a)-DOSE).
Am Heart J 2022;
251: 61-69
DOI: 10.1016/j.ahj.2022.05.004.
We do not assume any responsibility for the contents of the web pages of other providers.